Pneumocystis Pneumonia

Current Concepts in Pathogenesis, Diagnosis, and Treatment

Bryan J. Krajicek, Charles F. Thomas, Andrew Harold Limper

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Pneumocystis pneumonia (PCP) is an infection of the lungs caused by the opportunistic fungal genus Pneumocystis. In humans, PCP is a serious and potentially life-threatening infection occurring in immunocompromised individuals, particularly those who have AIDS, or following immune suppression from malignancy, organ transplantation, or therapies for inflammatory diseases. Several recent studies have contributed to understanding of the biology and pathogenesis of the organism yielding new diagnostic approaches and therapeutic targets. Although trimethoprim-sulfamethoxazole remains the mainstay of prophylaxis and treatment, ongoing concerns for emerging Pneumocystis resistance supports the continuing investigation for novel therapeutic agents.

Original languageEnglish (US)
Pages (from-to)265-278
Number of pages14
JournalClinics in Chest Medicine
Volume30
Issue number2
DOIs
StatePublished - Jun 2009

Fingerprint

Pneumocystis Pneumonia
Pneumocystis
Sulfamethoxazole Drug Combination Trimethoprim
Organ Transplantation
Infection
Acquired Immunodeficiency Syndrome
Therapeutics
Lung
Neoplasms

Keywords

  • Acquired immunodeficiency syndrome (AIDS)
  • Immune suppression
  • Inflammation
  • Opportunistic infection
  • Pneumocystis pneumonia

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Pneumocystis Pneumonia : Current Concepts in Pathogenesis, Diagnosis, and Treatment. / Krajicek, Bryan J.; Thomas, Charles F.; Limper, Andrew Harold.

In: Clinics in Chest Medicine, Vol. 30, No. 2, 06.2009, p. 265-278.

Research output: Contribution to journalArticle

@article{4e96b4dd2fd84b2aa147c9ebd39edbed,
title = "Pneumocystis Pneumonia: Current Concepts in Pathogenesis, Diagnosis, and Treatment",
abstract = "Pneumocystis pneumonia (PCP) is an infection of the lungs caused by the opportunistic fungal genus Pneumocystis. In humans, PCP is a serious and potentially life-threatening infection occurring in immunocompromised individuals, particularly those who have AIDS, or following immune suppression from malignancy, organ transplantation, or therapies for inflammatory diseases. Several recent studies have contributed to understanding of the biology and pathogenesis of the organism yielding new diagnostic approaches and therapeutic targets. Although trimethoprim-sulfamethoxazole remains the mainstay of prophylaxis and treatment, ongoing concerns for emerging Pneumocystis resistance supports the continuing investigation for novel therapeutic agents.",
keywords = "Acquired immunodeficiency syndrome (AIDS), Immune suppression, Inflammation, Opportunistic infection, Pneumocystis pneumonia",
author = "Krajicek, {Bryan J.} and Thomas, {Charles F.} and Limper, {Andrew Harold}",
year = "2009",
month = "6",
doi = "10.1016/j.ccm.2009.02.005",
language = "English (US)",
volume = "30",
pages = "265--278",
journal = "Clinics in Chest Medicine",
issn = "0272-5231",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Pneumocystis Pneumonia

T2 - Current Concepts in Pathogenesis, Diagnosis, and Treatment

AU - Krajicek, Bryan J.

AU - Thomas, Charles F.

AU - Limper, Andrew Harold

PY - 2009/6

Y1 - 2009/6

N2 - Pneumocystis pneumonia (PCP) is an infection of the lungs caused by the opportunistic fungal genus Pneumocystis. In humans, PCP is a serious and potentially life-threatening infection occurring in immunocompromised individuals, particularly those who have AIDS, or following immune suppression from malignancy, organ transplantation, or therapies for inflammatory diseases. Several recent studies have contributed to understanding of the biology and pathogenesis of the organism yielding new diagnostic approaches and therapeutic targets. Although trimethoprim-sulfamethoxazole remains the mainstay of prophylaxis and treatment, ongoing concerns for emerging Pneumocystis resistance supports the continuing investigation for novel therapeutic agents.

AB - Pneumocystis pneumonia (PCP) is an infection of the lungs caused by the opportunistic fungal genus Pneumocystis. In humans, PCP is a serious and potentially life-threatening infection occurring in immunocompromised individuals, particularly those who have AIDS, or following immune suppression from malignancy, organ transplantation, or therapies for inflammatory diseases. Several recent studies have contributed to understanding of the biology and pathogenesis of the organism yielding new diagnostic approaches and therapeutic targets. Although trimethoprim-sulfamethoxazole remains the mainstay of prophylaxis and treatment, ongoing concerns for emerging Pneumocystis resistance supports the continuing investigation for novel therapeutic agents.

KW - Acquired immunodeficiency syndrome (AIDS)

KW - Immune suppression

KW - Inflammation

KW - Opportunistic infection

KW - Pneumocystis pneumonia

UR - http://www.scopus.com/inward/record.url?scp=64249144493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64249144493&partnerID=8YFLogxK

U2 - 10.1016/j.ccm.2009.02.005

DO - 10.1016/j.ccm.2009.02.005

M3 - Article

VL - 30

SP - 265

EP - 278

JO - Clinics in Chest Medicine

JF - Clinics in Chest Medicine

SN - 0272-5231

IS - 2

ER -